Literature DB >> 20395703

Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study.

Annibale Versari1, Lorenzo Camellini, Gabriele Carlinfante, Andrea Frasoldati, Franco Nicoli, Elisa Grassi, Carmine Gallo, Francesca P Giunta, Alessandro Fraternali, Diana Salvo, Mattia Asti, Francesco Azzolini, Veronica Iori, Romano Sassatelli.   

Abstract

PURPOSE: In this report, we compared endoscopic ultrasonography (EUS), multidetector CT (MDCT), and Ga-68 DOTATOC PET/CT in patients with neuroendocrine tumors (NETs). We report our experience with use of these methods in patients suspected to have duodenopancreatic primitive NET.
METHODS: Nineteen consecutive patients (mean age, 56; 21-80), who underwent both Ga-68 DOTATOC PET/CT and EUS between March 2007 and November 2008 were retrospectively included in the study (16 underwent MDCT). Suspicion of NET was confirmed by EUS-FNA and/or surgery. Operative characteristics of PET, EUS, and MDCT were compared.
RESULTS: Twenty-three neuroendocrine lesions were diagnosed in 13/19 patients. EUS, PET, and MDCT correctly identified as affected 13/13 (100%), 12/13 (92%), and 10/11 (91%) patients, respectively. On a lesion basis, EUS, PET, and MDCT identified correctly as NETs 22/23 (96%), 20/23 (87%), and 13/18 (72%) lesions (P = 0.08 EUS vs. CT). Both on a patient and on a lesion basis, specificity was 67%, 83%, and 80% for EUS, PET, and MDCT, respectively.
CONCLUSIONS: EUS, Ga-68 DOTATOC PET, and MDCT seem to have comparable accuracy in diagnosis of duodenopancreatic NET and their combination may allow an optimal preoperative diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395703     DOI: 10.1097/RLU.0b013e3181d6677c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  22 in total

1.  Wandering spleen on a 68Ga-DOTATOC-PET/CT scan.

Authors:  Nele Lips; Christophe M Deroose; Didier Bielen; Peter Bossuyt; Luc Mortelmans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-13       Impact factor: 9.236

Review 2.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

Review 3.  Laparoscopic resection of gastrointestinal neuroendocrine tumors with special contribution of radionuclide imaging.

Authors:  Andreas Shamiyeh; Michael Gabriel
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  State-of-the-art PET/CT of the pancreas: current role and emerging indications.

Authors:  Dushyant V Sahani; Pietro A Bonaffini; Onofrio A Catalano; Alexander R Guimaraes; Michael A Blake
Journal:  Radiographics       Date:  2012 Jul-Aug       Impact factor: 5.333

5.  Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.

Authors:  Giorgio Treglia; Paola Castaldi; Maria Felicia Villani; Germano Perotti; Chiara de Waure; Angelina Filice; Valentina Ambrosini; Nadia Cremonini; Monica Santimaria; Annibale Versari; Stefano Fanti; Alessandro Giordano; Vittoria Rufini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-06       Impact factor: 9.236

Review 6.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 7.  Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Jessica E Maxwell; Thomas M O'Dorisio; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2015-10-31       Impact factor: 3.495

Review 8.  68Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis.

Authors:  Michael M Graham; Xiaomei Gu; Timothy Ginader; Patrick Breheny; John J Sunderland
Journal:  J Nucl Med       Date:  2017-03-09       Impact factor: 10.057

Review 9.  Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.

Authors:  Håkan Geijer; Lars H Breimer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-20       Impact factor: 9.236

10.  Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas.

Authors:  Christine Schmid-Tannwald; Christoph M Schmid-Tannwald; John N Morelli; Ralph Neumann; Alexander R Haug; Nathalie Jansen; Konstantin Nikolaou; Nicolai Schramm; Maximilian F Reiser; Carsten Rist
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.